| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |